{"denoms":[{"counts":[{"groupId":"BG000","value":"548"}],"units":"Participants"}],"groups":[{"description":"Participants with solid tumors (other than metastatic melanoma or papillary thyroid cancer) or multiple myeloma who met the inclusion criteria and did not meet exclusion criteria of the study were enrolled and were evaluated for the presence of BRAF V600 mutations by collecting tumor samples or performing fresh biopsies according to local standards.","id":"BG000","title":"Participants With Confirmed Solid Tumors or Multiple Myeloma"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"12.38","value":"63.3"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"326"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"222"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Gender","unitOfMeasure":"Participants"}],"populationDescription":"All the participants who were enrolled and were evaluable for the BRAF V600 mutations were included in the analysis."}